These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26992417)

  • 1. Transformative therapy in hypophosphatasia.
    Bishop N; Munns CF; Ozono K
    Arch Dis Child; 2016 Jun; 101(6):514-515. PubMed ID: 26992417
    [No Abstract]   [Full Text] [Related]  

  • 2. Cutis laxa-like calcinosis cutis secondary to asfotase alfa in juvenile-onset hypophosphatasia.
    Charalambides M; Rooke B; Cain O; Geberhiwot T; Bader E
    Clin Exp Dermatol; 2020 Dec; 45(8):1103-1105. PubMed ID: 32716093
    [No Abstract]   [Full Text] [Related]  

  • 3. Asfotase alfa (Strensiq) for hypophosphatasia.
    Med Lett Drugs Ther; 2016 Jul; 58(1499):e96. PubMed ID: 27403786
    [No Abstract]   [Full Text] [Related]  

  • 4. Enzyme-replacement therapy in life-threatening hypophosphatasia.
    Whyte MP; Greenberg CR; Salman NJ; Bober MB; McAlister WH; Wenkert D; Van Sickle BJ; Simmons JH; Edgar TS; Bauer ML; Hamdan MA; Bishop N; Lutz RE; McGinn M; Craig S; Moore JN; Taylor JW; Cleveland RH; Cranley WR; Lim R; Thacher TD; Mayhew JE; Downs M; Millán JL; Skrinar AM; Crine P; Landy H
    N Engl J Med; 2012 Mar; 366(10):904-13. PubMed ID: 22397652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asfotase Alfa in Perinatal/Infantile-Onset and Juvenile-Onset Hypophosphatasia: A Guide to Its Use in the USA.
    Scott LJ
    BioDrugs; 2016 Feb; 30(1):41-8. PubMed ID: 26832358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypophosphatasia: From Diagnosis to Treatment.
    Simon S; Resch H; Klaushofer K; Roschger P; Zwerina J; Kocijan R
    Curr Rheumatol Rep; 2018 Sep; 20(11):69. PubMed ID: 30203264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme Replacement Therapy in Hypophosphatasia.
    Uçaktürk SA; Elmaogullari S; Ünal S; Gönülal D; Mengen E
    J Coll Physicians Surg Pak; 2018 Sep; 28(9):S198-S200. PubMed ID: 30173697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful Use of Enzyme Replacement Therapy in Infantile Hypophosphatasia.
    Simm PJ; Savarirayan R
    J Paediatr Child Health; 2017 Sep; 53(9):925-926. PubMed ID: 28868782
    [No Abstract]   [Full Text] [Related]  

  • 9. Asfotase Alfa Treatment Improves Survival for Perinatal and Infantile Hypophosphatasia.
    Whyte MP; Rockman-Greenberg C; Ozono K; Riese R; Moseley S; Melian A; Thompson DD; Bishop N; Hofmann C
    J Clin Endocrinol Metab; 2016 Jan; 101(1):334-42. PubMed ID: 26529632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reappearance of hypomineralized bone after discontinuation of asfotase alfa treatment for severe childhood hypophosphatasia.
    Bowden SA; Adler BH
    Osteoporos Int; 2018 Sep; 29(9):2155-2156. PubMed ID: 29967930
    [No Abstract]   [Full Text] [Related]  

  • 11. Enzyme replacement therapy for congenital hypophosphatasia allows for surgical treatment of related complex craniosynostosis: a case series.
    Kosnik-Infinger L; Gendron C; Gordon CB; Pan BS; van Aalst JA; Vogel TW
    Neurosurg Focus; 2015 May; 38(5):E10. PubMed ID: 25929963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypophosphatasia: Canadian update on diagnosis and management.
    Khan AA; Josse R; Kannu P; Villeneuve J; Paul T; Van Uum S; Greenberg CR
    Osteoporos Int; 2019 Sep; 30(9):1713-1722. PubMed ID: 30915507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of treatment with asfotase alfa in patients with hypophosphatasia: Results from a Japanese clinical trial.
    Kitaoka T; Tajima T; Nagasaki K; Kikuchi T; Yamamoto K; Michigami T; Okada S; Fujiwara I; Kokaji M; Mochizuki H; Ogata T; Tatebayashi K; Watanabe A; Yatsuga S; Kubota T; Ozono K
    Clin Endocrinol (Oxf); 2017 Jul; 87(1):10-19. PubMed ID: 28374482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lethal hypophosphatasia successfully treated with enzyme replacement from day 1 after birth.
    Okazaki Y; Kitajima H; Mochizuki N; Kitaoka T; Michigami T; Ozono K
    Eur J Pediatr; 2016 Mar; 175(3):433-7. PubMed ID: 26459154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Asfotase Alfa on Muscle Weakness in a Japanese Adult Patient of Hypophosphatasia with Low ALP Levels.
    Koyama H; Yasuda S; Kakoi S; Ohata Y; Shimizu Y; Hasegawa C; Hayakawa A; Akiyama T; Yagi T; Aotani D; Imaeda K; Ozono K; Kataoka H; Tanaka T
    Intern Med; 2020 Mar; 59(6):811-815. PubMed ID: 31787692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Asfotase Alfa in Infants and Young Children With Hypophosphatasia: A Phase 2 Open-Label Study.
    Hofmann CE; Harmatz P; Vockley J; Högler W; Nakayama H; Bishop N; Martos-Moreno GÁ; Moseley S; Fujita KP; Liese J; Rockman-Greenberg C;
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2735-2747. PubMed ID: 30811537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme-replacement therapy in perinatal hypophosphatasia: Case report and review of the literature.
    Rougier H; Desrumaux A; Bouchon N; Wroblewski I; Pin I; Nugues F; Mornet E; Baujat G
    Arch Pediatr; 2018 Oct; 25(7):442-447. PubMed ID: 30249491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant Enzyme Replacement Therapy in Hypophosphatasia.
    Hofmann C; Jakob F; Seefried L; Mentrup B; Graser S; Plotkin H; Girschick HJ; Liese J
    Subcell Biochem; 2015; 76():323-41. PubMed ID: 26219718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asfotase alfa treatment for 1 year in a 16 year-old male with severe childhood hypophosphatasia.
    Bowden SA; Adler BH
    Osteoporos Int; 2018 Feb; 29(2):511-515. PubMed ID: 29046930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial.
    Whyte MP; Simmons JH; Moseley S; Fujita KP; Bishop N; Salman NJ; Taylor J; Phillips D; McGinn M; McAlister WH
    Lancet Diabetes Endocrinol; 2019 Feb; 7(2):93-105. PubMed ID: 30558909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.